| For medical practitioners and the general public - Cholesterol Journal Article Catalog. |
| First Page | Previous Page | Next Page | Last Page |
| Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1) Bairaktari, E., M. Elisaf, et al. (2001), Clin Biochem 34(8): 593-602. Abstract: OBJECTIVES: Current recommendations for the management of dyslipidemia are largely based on the concentration of LDL-C. Most clinical laboratories estimate the concentration of LDL-C by the recommended routine method, the equation of Friedewald, in specimens from fasting subjects and with TG concentrations < 4.52 mmol/L. Because of the limitations of the Friedewald calculation, direct methods for an accurate quantification of LDL-C are needed. DESIGN AND METHODS: In the present study we evaluated the accuracy of the following 5 different procedures for LDL-C in 98 patients on hemodialysis: the Friedewald equation, where LDL-C is calculated from HDL-C, measured either by the precipitation procedure with dextran sulfate-Mg(2+) (Method 1), or by a direct HDL-C assay (Method 2), the Direct LDL assay (Method 3), the homogeneous N-geneous LDL assay (Method 4) and the calculated LDL-C values deriving from the ApoB based equation: 0.41TC - 0.32TG + 1.70ApoB - 0.27, (Clin Chem 1997;43:808-815) (Method 5). RESULTS: All five LDL-C methods were found to be in good agreement with ultracentrifugation/dextran sulfate-Mg(2+) precipitation with the coefficients of correlation of the assays to ranging between 0.93-0.95. However, significant differences in the mean values and biases vs. the reference method were observed. The Friedewald equation and the Direct assay were less affected by high LDL-C levels, and they presented higher sensitivity and higher negative predictive value. The N-geneous assay and the ApoB derived calculation were less affected by high triglyceride levels, and they presented higher specificity and higher positive predictive value. At the diagnostic LDL-C level of 3.37 mmol/L, both Friedewald calculations correctly classified 82/92 patients; Direct assay 86/98; N-geneous assay 88/98; and ApoB derived calculation 88/98. At the diagnostic LDL-C level of 2.98 mmol/L, Friedewald calculations (Method 1 and Method 2) correctly classified 82/92 and 81/92 patients, respectively; Direct assay (LDL-3) 87/98; N-geneous assay (LDL-4) 91/98; and ApoB derived calculation (LDL-5) 91/98. CONCLUSIONS: Among hemodialysis patients, who commonly present "average" LDL-C concentrations and high TG levels, the N-geneous assay and the apoB derived calculation seem to yield more acceptable results for the estimation of LDL-C. |
| Evaluation of glucose and cholesterol levels in the mother and newborn infant in the perinatal period Osuch-Jaczewska, R., B. Koehler, et al. (1992), Wiad Lek 45(7-8): 284-6. Abstract: In 30 live born newborns the connections were assessed between glucose and cholesterol levels in umbilical cord blood after birth, and also in maternal blood before and two days after birth. Statistically significant differences of glucose and cholesterol levels were found between mothers and newborns in the perinatal period. Attention is called to greater independence of cholesterol (total, free and esterified) levels in newborn and mother in perinatal period. |
| Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency Akita, H., H. Chiba, et al. (1995), Hum Genet 96(5): 521-6. Abstract: The effect of a polymorphism, guanine (G) to adenine (A) substitution in the promoter of apolipoprotein A-I gene at a position 78 bp upstream of the transcription initiation site, on the serum high-density lipoprotein (HDL)-cholesterol level was studied in 168 Japanese subjects with HDL-cholesterol levels ranging from 26 to 171 mg/dl. Considering the significant effect of cholesteryl ester transfer protein (CETP) on the HDL-cholesterol level and the common occurrence of its deficiency, we performed statistical analyses separately for two groups: one without CETP deficiency (n = 126) and the other with CETP deficiency (n = 42). In the group without CETP deficiency, in which the numbers of G/G, G/A, and A/A genotypes were 92 (73.0%), 28 (22.2%), and 6 (4.8%), respectively, the frequency of the A allele in the subjects with HDL-cholesterol levels of > or = 70 mg/dl did not differ from subjects with HDL-cholesterol levels of < or = 69 mg/dl, irrespective of gender: 0.154 and 0.145 in males, and 0.182 and 0.174 in females, respectively, for the > or = 70 mg/dl and < or = 69 mg/dl groups. Additionally, the HDL-cholesterol levels for the subjects with the G/G genotype did not differ from those for the subjects with the A allele: 64 +/- 22, 58 +/- 14, 77 +/- 14 and 62 +/- 16 mg/dl, respectively, for the G/G, G/A, A/A, and G/A + A/A in males, and 72 +/- 18, 74 +/- 24, 63 +/- 4, and 73 +/- 23 mg/dl in females. For the group with CETP deficiency, in which the numbers of G/G and G/A + A/A genotypes were 25 (59.5%) and 17 (40.5%), the HDL-cholesterol levels also did not differ: 98 +/- 24 mg/dl and 99 +/- 30 mg/dl, respectively, for the G/G and G/A + A/A genotypes. Thus, there is no evidence that the polymorphism has any effect on serum HDL-cholesterol levels regardless of CETP status. We conclude that the G-to-A substitution in the promoter of apolipoprotein A-I gene does not significantly alter serum HDL-cholesterol level. |
| Evaluation of hesperetin 7-O-lauryl ether as lipid-lowering agent in high-cholesterol-fed rats Choi, G. S., S. Lee, et al. (2004), Bioorg Med Chem 12(13): 3599-605. Abstract: The lipid-lowering efficacy of hesperetin was revealed in preliminary studies on experimental animals. As such, the current study compared the effect of hesperetin 7-O-lauryl ether, with that of hesperetin and lovastatin on the lipid profile and cholesterol-regulating mechanism in high-cholesterol-fed rats. Male rats were fed a high-cholesterol diet (1%, wt/wt) or high-cholesterol diet supplemented with lovastatin (1, 0.02%, wt/wt), hesperetin (2, 0.02%, wt/wt), or hesperetin 7-O-lauryl ether (3, 0.031%, wt/wt) for six weeks. The supplemental amount of 3 was 0.066mmol/100g diet as an equivalent to the supplemental amount of 2. The plasma total cholesterol and triglyceride levels were significantly lowered by the 2 and 3 supplements compared with the control or 1-supplemented group. The hepatic HMG-CoA reductase activities were also significantly lower in all the supplemented groups compared with the control group, and the hepatic ACAT activity was significantly lower in the 2- and 3-supplemented groups. The supplementation of 3 resulted in a higher excretion of total neutral sterol and total fecal sterol compared with the control or 1-supplemented group. Accordingly, overall, compound 3, exhibited a more potent plasma lipid-lowering effect than compound 1 based on inhibiting cholesterol biosynthesis and esterification, while also increasing the fecal sterol excretion. |
| Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 analyzer Lin, M. J., C. Hoke, et al. (1998), Clin Chem 44(5): 1050-2. |
| Evaluation of implementation of a cholesterol management program in physicians' offices Glanz, K., M. Brekke, et al. (1992), Health Educ Res 7(2): 151-63. Abstract: This article describes an evaluation of the implementation of a cholesterol management program in family physicians' offices as part of the Physician-Based Nutrition Program to Lower Coronary Heart Disease Risk (PBNP). The evaluation, conducted through a partnership evaluation model, used multiple case study methodology and combined the use of quantitative and qualitative methods. Data sources included office staff reports and interviews, records of contacts with study personnel, patient care data, and patient telephone interviews. Data from these sources revealed gradual program implementation and considerable variation in practitioner and clinic involvement in cholesterol management. Clinic staff reported that the support provided by PBNP in the form of training, operations materials, patient education materials and ongoing assistance was very useful. This formative evaluation has implications for refinement of the PBNP and for other prevention programs in primary care settings. It demonstrates the feasibility and acceptability of a systems approach to physicians, cholesterol/nutrition educators and clinic support staff. It also suggests ways in which researchers and clinicians can implement and evaluate health care innovations. |
| Evaluation of LDL-cholesterol measurement Kubo, N. (2002), Rinsho Byori 50(3): 242-7. Abstract: As a result of increased recognition of elevated LDL-cholesterol (LDL-C) as a risk for ischemic heart disease, the necessity for LDL-C measurement emerged in clinical laboratories. Consequently various LDL-C measurement methods were developed. The objective of the present review article is to compare and to evaluate the characteristics of various methods for LDL-C measurement. Because LDL is a particle defined by its density, ultracentrifugation method; beta-quantification is currently considered the reference method, but it is a time-consuming and expensive technique. The evaluation by Friedewald's equation is simple and applicable to the vast majority of normolipidemic samples. LDL-C measurement by electrophoresis provides an evaluation of LDL along with other lipoproteins. Homogeneous assays have the advantage of obviating the need for pretreatment of samples, and this is suitable for online performance, requiring only a few microliters of sample. Generally, there is little disagreement between methods in LDL-C data of normolipidemic samples. However, when the sample is from patients with dyslipidemia, there may be disagreement in LDL-C results between methods and the reason for this phenomena has been discussed. At the moment, the method for LDL-C measurement at each clinical laboratory has to be selected by adequately balancing demands, costs and benefits. |
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol Bairaktari, E. T., K. I. Seferiadis, et al. (2005), J Cardiovasc Pharmacol Ther 10(1): 45-54. Abstract: A high concentration of low-density lipoprotein cholesterol (LDL-C) in plasma is one of the strongest risk factors for atherosclerotic cardiovascular disease and mortality. The most common approach to determining LDL-C in the clinical laboratory is the Friedewald calculation. There is an increased interest to improve the accuracy of LDL-C estimated by this equation. The expert panel convened by National Cholesterol Education Program has recommended the development of accurate direct methods to measure LDL-C. Several homogeneous and fully automated methods have been introduced in recent years that show improved precision and accuracy over earlier methods, especially the Friedewald calculation. Each of the atherogenic particles in plasma--very-low, intermediate-, and low- density lipoprotein--as well as lipoprotein (a), contain one molecule of apolipoprotein B (apoB) and thus, plasma total concentration of apoB reflects the number of atherogenic particles. Several studies suggested that the measurement of apoB could improve the prediction of risk of coronary artery disease. Thus, in addition to the newly developed direct assays, alternative calculation procedures have been proposed that also take into consideration total serum apoB concentration for the estimation of LDL-C and the presence of small, dense LDL particles. The new generation of homogenous methods for the measurement of LDL-C and the use of serum apoB concentration for the estimation of LDL-C can contribute to the accurate LDL-C determination. |
| Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits Goldberg, D. I., W. F. Beltz, et al. (1991), J Clin Invest 87(1): 331-46. Abstract: Cholesterol esters (CE) formed in HDL by lecithin:cholesterol acyltransferase are thought to mediate the return of cholesterol from extrahepatic tissues to the liver for excretion or reutilization. Several pathways may be involved in that process. Tracer kinetics were used to estimate the contributions of the various pathways to cellular uptake of HDL CE in rabbits. Tracers of HDL CE, HDL apo A-I, LDL apo B, and VLDL CE were simultaneously injected intravenously. Plasma decays were followed for 24 h in 4 lipoprotein pools: HDL without apo E, HDL with apo E, LDL, and VLDL. Kinetic analysis of the resulting plasma decay curves revealed that the preponderance of plasma CE (greater than 90%) originated in the HDL fraction. About 70% of HDL CE were cleared from plasma after transfer to LDL and VLDL, 20% were cleared directly from the HDL pool without HDL particle uptake ("selective" uptake), and 10% were cleared in HDL particles (including particles containing apo E). Since rabbits have about four times the plasma cholesterol ester transfer activity of man, and since the transfer pathway must compete with the selective uptake pathway, these results make it likely that selective uptake plays a substantial role in humans in the clearance of HDL CE. |
| Evaluation of precipitation and direct methods for HDL-cholesterol assay by HPLC Okazaki, M., K. Sasamoto, et al. (1997), Clin Chem 43(10): 1885-90. Abstract: HDL-cholesterol (HDL-C) values measured by precipitation (sodium phosphotungstate-MgCl2) and direct methods were compared with those obtained by HPLC with a new column (TSKgel Lipopropak) and an eluent (TSKeluent LP-1). The HDL-C values determined by the precipitation method were significantly (P <0.001) lower than those by the HPLC method, whereas the HDL-C values by the direct method were slightly but significantly higher (P <0.02) than those by the HPLC method. A quantitative HPLC analysis of the cholesterol concentration in HDL and non-HDL fractions in the supernatant of serum separated by precipitation reagents with different MgCl2 concentrations ranging from 7.3 to 44 mmol/L revealed that reagents with >22 mmol/L MgCl2 precipitated part of HDL as well as non-HDL lipoproteins. The HPLC method providing quantitative and qualitative information with high precision was regarded as being a reliable approach for HDL-C assay. The HPLC can be also used to evaluate alternative methods for cholesterol assay. |
| Evaluation of referral completion after a workplace cholesterol screening program Fitzgerald, S. T., S. Gibbens, et al. (1991), Am J Prev Med 7(6): 335-40. Abstract: We designed a randomized clinical trial to examine effectiveness of a follow-up educational mailing to improve referral completion following a workplace cholesterol screening program. Of 836 employees who participated in a cholesterol screening program at Blue Cross and Blue Shield of Maryland, 313 (37%) had a total cholesterol greater than or equal to 200 mg/dL and were referred to their physician for remeasurement and evaluation. Individuals with elevated cholesterol who agreed to a telephone interview two months after screening (n = 272) were randomized to a control or intervention group. The intervention consisted of a booster mailing two weeks after screening designed to encourage further physician follow-up and to increase knowledge about cholesterol and its dietary control and about risk factors for coronary heart disease (CHD). No statistically significant differences appeared between the control and intervention groups in rate of referral completion. However, a blood cholesterol level of greater than or equal to 240 mg/dL at the time of screening was the most significant predictor of referral completion (P less than.0001). Of those randomized, the association between the number of other additional risk factors for CHD and referral completion was not statistically significant. There was, however, a trend toward reported changes in lifestyle behavior as a result of screening, particularly in diet modification. |
| Evaluation of serum cholesterol and triglyceride levels in 1-6-year-old Saudi children El-Hazmi, M. A. and A. S. Warsy (2001), J Trop Pediatr 47(3): 181-5. Abstract: Estimations of cholesterol and triglyceride in serum are frequently requested tests due to the close association between elevated levels of these parameters and the risk of arteriosclerosis later leading to cardiovascular disease. Since lipid levels in children show considerable variations in different populations, this study was conducted with the aim of investigating levels of cholesterol and triglycerides in Saudi children less than 6 years old. The study group comprised 582 children with ages ranging from 1 to 6 years, randomly selected during a household screening programme. Fasting blood was used for the estimation of cholesterol and triglyceride using an autoanalyser. The overall range for cholesterol was 2.1-5.7 mmol/l and for triglyceride it was 0.1-1.84 mmol/l. The children were separated into five further groups depending on age, and the levels of cholesterol and triglycerides were obtained in each age group. Using published guidelines for cholesterol and triglyceride levels, to estimate 'borderline' and 'high risk' for arteriosclerosis and coronary artery disease, the prevalence of both risk groups were calculated in Saudi children. A total of 6.87 per cent of children fell in the borderline risk and 1.55 per cent in the high-risk group using cholesterol levels, while 1.89 per cent fell in the borderline-risk group and 1.2 per cent in the high-risk group using triglyceride levels. This paper presents the lipid values and discusses the need for lipid awareness programmes in the country. |
| Evaluation of seven Cholestech L.D.X analyzers for total cholesterol determinations Rogers, E. J., L. Misner, et al. (1993), Clin Chem 39(5): 860-4. Abstract: We assessed the performance of seven Cholestech L.D.X lipid analyzers under tightly controlled laboratory conditions for accuracy and precision in accordance with analytical guidelines of the National Cholesterol Education Program (NCEP). Venous heparinized whole blood (VB) and plasma (VP), venous serum (VS), and capillary fingerstick whole blood (FB) were collected from 18 individuals. Total cholesterol (TC) concentration was measured in VB, VP, and VS on all seven instruments. Three instruments were used for TC measurements of FB. Reference cholesterol values for each individual were generated in the same laboratory with a standardized method. The within-run coefficients of variation (CVs) for all instruments with a Level I pool (1560 mg/L, n = 10) ranged from 1.3% to 1.8% (mean = 1.59%). The between-run CVs with the same pool ranged from 2.2% to 3.4% (mean = 2.84%, n = 10). Correlation coefficients derived from comparison of total cholesterol values generated by the instruments for each specimen type vs the reference cholesterol values were all > 0.97. The average bias for all instruments for each sample type was 1.9% (FB), 4.3% (VB), 6.6% (VP), and 7.0% (VS). Predicted cholesterol concentration for each sample type from regression curves for total cholesterol at the suggested NCEP clinical decision cutoff values of 2000 and 2400 mg/L, respectively, were 2049 and 2431 mg/L for FB, 2081 and 2469 mg/L for VB, 2122 and 2522 mg/L for VP, and 2121 and 2521 mg/L for VS. |
| Evaluation of the Accutrend GC for cholesterol determination Aragones Benaiges, E. (1996), Aten Primaria 18(9): 528, 530-1. |
| Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood Cobbaert, C., G. J. Boerma, et al. (1994), Eur J Clin Chem Clin Biochem 32(5): 391-4. Abstract: The analytical performance of the Cholestech L.D.X. lipid analyzer for total and HDL-cholesterol and triacylglycerols in heparinized venous blood was evaluated, using two Cholestech L.D.X. analysers and two reagent cassette lots. Within-day and day-to-day precision were checked with commercial quality control sera. Within-day coefficients of variation (CVs) were 2.0 to 4.7% for total cholesterol, 3.4 to 5.5% for HDL-cholesterol, and 2.1 to 4.8% for triacylglycerols. Between-day CVs were < or = 6.0% for triacylglycerols, and < or = 7.0% for HDL-cholesterol. A method comparison study, according to the NCCLS EP9-P guidelines, was performed for all three analytes. Cholestech whole blood values (y) were compared with serum values (x) generated by a standardized enzymatic method for cholesterol, and by current state-of-the-art methodology for HDL-cholesterol and triacylglycerols. Correlation coefficients were all > 0.98. Mean slopes and intercepts for the Passing & Bablok regression equations of total and HDL-cholesterol were not significantly different from one and zero, respectively. Overall, the Cholestech means differed by < 1.8% for total cholesterol, and < 5% for HDL-cholesterol versus the comparison method means. For total cholesterol the National Cholesterol Education Program (NCEP) requirements for accuracy and precision of < or = 3% were met. For triacylglycerols, significant negative intercepts ranging from -0.26 to -0.33 mmol/l were observed, with slopes significantly greater than one. |
| Evaluation of the cholesterol influence in type II collagen-induced arthritis in DBA/1J mice: an autoradiographic study Hamer, E. R., M. I. Apfel, et al. (2002), J Cell Mol Med 6(3): 407-14. Abstract: In order to verify the cholesterol influence in RA severity in DBA/1J mice, we quantified the cholesterol present in the knee joints of normal (N) and with collagen II induced arthritis (CIA). Forty male DBA/1J mice, were divided in normal (n=20) and CIA group (n=20). Mice in CIA group were injected with 100 microg of collagen II emulsified in Freund's complete adjuvant. Sixteen DBA/1J (8 N and 8 CIA) received an injection of 2.96 x 10(6) Bq of (3)H-cholesterol and were anesthetized and sacrificed. Semi-fine sections were covered with LM-1 emulsion, exposed for six weeks and developed. Collagen induced edema, erythema and dysfunction of knee joints in CIA group. Radioactive cholesterol was located more on the synovial membrane, where we found the greatest density of silver grains, significantly (P<0.0001) higher in group CIA vs. controls (61-/+2.3 X 18-/+0.7). We conclude that the cholesterol deposits on the synovial membrane is related to CIA severity. |
| Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age Binaghi, P., G. Cellina, et al. (1990), Minerva Med 81(6): 475-9. Abstract: Cardiovascular diseases are the main cause of death also in women. Their incidence, rapidly growing in the peri-menopausal period, is related to serum levels of total cholesterol and its LDL fraction. It was also shown that the peroxidation of LDL is an additional factor in the genesis of atherosclerotic vascular disease. As long-term treatments with synthetic lipid-lowering drugs may cause undesirable side effects, while pantethine is known to be well tolerated, we treated 24 hypercholesterolemic women (total serum cholesterol greater than or equal to 240 mg/dl), in perimenopausal age (range: 45-55 years, mean +/- SD = 51.6 +/- 2.4) with 900 mg/day of pantethine. This is a precursor of coenzyme A, with an antiperoxidation effect in vivo, and our aim was to confirm its lipid lowering activity in this particular type of patients. After 16 weeks of treatment, significant reductions of total cholesterol, LDL-cholesterol and LDL-C/HDL-C ratio could be observed. No remarkable changes of the main laboratory parameters (fasting blood sugar, B.U.N., creatinine, uric acid) were seen. Efficacy percentages of the treatment were about 80%. None of the patients complained of adverse reactions due to the treatment with pantethine. In conclusion, we suggest that pantethine should be considered in the long-term treatment of lipid derangements occurring in the perimenopausal age. |
| Evaluation of the cytotoxic effects of some oxysterols and of cholesterol on endothelial cell growth: methodological aspects Lizard, G., S. Gueldry, et al. (1997), Pathol Biol (Paris) 45(4): 281-90. Abstract: The effects of various oxysterols (7 beta-hydroxycholesterol, 7-ketocholesterol, 19-hydroxycholesterol, cholesterol-5 alpha, 6 alpha-epoxide, and 25-hydroxycholesterol) and of cholesterol were investigated on cell growth of bovine aortic endothelial (BAE) cells by cell counting, MTT reduction, and 3H-thymidine incorporation in a 5 to 80 micrograms/ml concentration range. By cell counting, a dose related decrease in the number of adherent cells was observed with oxysterols; MTT reduction also indicated a decreased number of viable cells, and both method give similar IC50. A lower 3H-thymidine incorporation was generally detected with oxysterols but no effect on 3H-thymidine incorporation was found with 25-hydroxycholesterol. With cholesterol, no modification of cell growth was shown by cell counting and 3H-thymidine incorporation, whereas an important decrease in MTT reduction was observed. Noteworthy, with the highest cholesterol concentration no change in cellular morphology occurred, and no modification of mitochondrial activity was found with Rhodamine 123. It is concluded that MTT and 3H-thymidine incorporation are not suitable for the evaluation of a putative toxicity of cholesterol and 25-hydroxycholesterol, respectively. Therefore, cell counting seems the most accurate method to determine the effects of oxysterols and of cholesterol on endothelial cell growth. |
| Evaluation of the determination of total cholesterol in Chilean clinical laboratories Quiroga, T., M. Goycoolea, et al. (1993), Rev Med Chil 121(6): 667-72. Abstract: The precise and accurate measurement of total cholesterol is necessary to correctly identify hypercholesterolemia. The aim of this study was to assess the measurement of serum cholesterol in clinical laboratories using as acceptability criteria the recommendations of the "National Cholesterol Education Program" (that consider acceptable a deviation < 5% from the real value and ideal a deviation < or = 3%). In each of three assessments, three pools of lyophilized sera with different levels of cholesterol were used method. Twenty nine to 42.3% of laboratories had results within the ideal interval and 49.5 to 60% within the acceptable range of deviation. In the last assessment, only 17% of laboratories had their three values within the ideal range. Only 39.4% of laboratories use 200 mg/dl as the cut off point to diagnose hypercholesterolemia. It is concluded that the standardization of cholesterol measurement and the use of a common cut off point to diagnose hypercholesterolemia must be emphasized. |
| Evaluation of the high density lipoprotein cholesterol protective effect against atherogenesis in rabbits fed cholesterol supplemented diets Neuman, M. P., J. Neuman, et al. (1990), Medicina (B Aires) 50(4): 343-50. Abstract: Plasma high density lipoprotein cholesterol (HDL-C) was evaluated in 15 rabbits fed cholesterol supplemented diets to assess its protective effect on the atherogenic process. From a baseline level of 29 +/- 11 mg/dl (mean +/- SD) the maximum attained for HDL-C was twofold in only three rabbits, whereas total cholesterol (TC) increased 20 fold. Plasma TC/HDL-C ratio rose 80 fold from the baseline (2.4 +/- 0.9) and it was the best parameter that correlated with aortic cholesterol accumulation and pathological scores. Aortic TC content increased 10 fold and free cholesterol/cholesterol esters ratio decreased 20 fold. Pathological studies showed that aortic lesion scores rose from 0 to 4. It can be concluded that the high correlations obtained when TC/HDL-C ratio was plotted against both aortic cholesterol deposition and lesion scores, support the theory of the reverse cholesterol transport and the effectiveness of this index to predict the degree of the atherogenic process. On the other hand, the poor response of HDL-C in this model encourages future research using drugs to increase this parameter in order to normalize TC/HDL-C ratio and avoid lesions. |